pyridine has been researched along with Peritonitis in 2 studies
azine : An organonitrogen compound of general structure RCH=N-N=CHR or RR'C=N-N=CRR'.
Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Until these results are confirmed with appropriate in vivo studies, intermittent intraperitoneal dosing of ceftazidime admixed with icodextrin should be used with caution and appropriate clinical monitoring or a suitable alternative antibiotic should be used." | 5.51 | High Pyridine Generation in Ceftazidime-Icodextrin Admixtures Used to Treat Peritoneal Dialysis-associated Peritonitis. ( Castelino, RL; Harmanjeet, H; Jose, MD; Kaur, H; Patel, RP; Peterson, GM; Sud, K; Wanandy, T, 2019) |
| " Depending on the type of PD solution, ceftazidime is exposed to an environment with acidic or basic pH, and depending on the type of dosing and individual unit practices related to preparation and storage, ceftazidime can be at body temperature for 4-10 h, resulting in potentially varying rates of degradation to pyridine by-product." | 1.56 | Pyridine levels in ceftazidime - peritoneal dialysis admixtures stored at body temperature. ( Castelino, RL; Harmanjeet, H; Jose, MD; Nguyen, TT; Patel, RP; Peterson, GM; Sud, K; Wanandy, T; Zaidi, STR, 2020) |
| "Until these results are confirmed with appropriate in vivo studies, intermittent intraperitoneal dosing of ceftazidime admixed with icodextrin should be used with caution and appropriate clinical monitoring or a suitable alternative antibiotic should be used." | 1.51 | High Pyridine Generation in Ceftazidime-Icodextrin Admixtures Used to Treat Peritoneal Dialysis-associated Peritonitis. ( Castelino, RL; Harmanjeet, H; Jose, MD; Kaur, H; Patel, RP; Peterson, GM; Sud, K; Wanandy, T, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, H | 1 |
| Harmanjeet, H | 2 |
| Wanandy, T | 2 |
| Castelino, RL | 2 |
| Sud, K | 2 |
| Jose, MD | 2 |
| Peterson, GM | 2 |
| Patel, RP | 2 |
| Nguyen, TT | 1 |
| Zaidi, STR | 1 |
2 other studies available for pyridine and Peritonitis
| Article | Year |
|---|---|
High Pyridine Generation in Ceftazidime-Icodextrin Admixtures Used to Treat Peritoneal Dialysis-associated Peritonitis.
Topics: Anti-Bacterial Agents; Ceftazidime; Dialysis Solutions; Drug Combinations; Drug Stability; Icodextri | 2019 |
Pyridine levels in ceftazidime - peritoneal dialysis admixtures stored at body temperature.
Topics: Anti-Bacterial Agents; Body Temperature; Ceftazidime; Dialysis Solutions; Drug Stability; Drug Stora | 2020 |